The HSP90 inhibitor NVP-AUY922-AG inhibits the PI3K and IKK signalling pathways and synergizes with cytarabine in acute myeloid leukaemia cells-Reference-Cited by-同舟云学术

The HSP90 inhibitor NVP-AUY922-AG inhibits the PI3K and IKK signalling pathways and synergizes with cytarabine in acute myeloid leukaemia cells

Published:2013-01-29 Issue:1 Volume:161 Page:57-67
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Walsby Elisabeth J.¹,Lazenby Michelle¹,Pepper Chris J.²,Knapper Steven¹,Burnett Alan K.²

Affiliation:

1. Cardiff Experimental Cancer Medicine Centre, Institute of Cancer and Genetics, Institute of Cancer and Genetics, School of Medicine, Cardiff University; ardiff; UK

2. Department of Haematology; Institute of Cancer and Genetics, School of Medicine, Cardiff University; Cardiff; UK

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12215/fullpdf

Reference51 articles.

1. Targeting cell signaling pathways for drug discovery: an old lock needs a new key;Aggarwal;Journal of Cellular Biochemistry,2007

2. Heat shock protein 90 as a drug target: some like it hot;Banerji;Clinical Cancer Research,2009

3. The clinical applications of heat shock protein inhibitors in cancer - present and future;Banerji;Current Cancer Drug Targets,2003

4. Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function;Basso;Journal of Biological Chemistry,2002

5. Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity;Boll;Clinical Cancer Research,2009

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting hematological malignancies with isoxazole derivatives;Drug Discovery Today;2024-08

2. Mesenchymal stem cell-derived exosomes ameliorate hypoxic pulmonary hypertension by inhibiting the Hsp90aa1/ERK/pERK pathway;Biochemical Pharmacology;2024-08

3. Role of Ganetespib, an HSP90 Inhibitor, in Cancer Therapy: From Molecular Mechanisms to Clinical Practice;International Journal of Molecular Sciences;2023-03-06

4. A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia;Lipids in Health and Disease;2022-08-25

5. NF-κB: A Druggable Target in Acute Myeloid Leukemia;Cancers;2022-07-21